{
    "clinical_study": {
        "@rank": "36888", 
        "arm_group": [
            {
                "arm_group_label": "CN + combusted & non-combusted products", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will be asked to smoke the assigned conventional nicotine content (CN) cigarettes, instead of their normal brand, for 8 weeks and will also be given access to use other combusted and non-combusted tobacco and medicinal nicotine products during that time."
            }, 
            {
                "arm_group_label": "VLNC + combusted & non-combusted products", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will be asked to smoke the assigned very low nicotine content (VLNC) cigarettes, instead of their normal brand,  for 8 weeks and will also be given access to use other combusted and non-combusted tobacco and medicinal nicotine products during that time."
            }, 
            {
                "arm_group_label": "VLNC with non-combusted products", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will be asked to smoke very low nicotine content (VLNC) cigarettes instead of their usual cigarettes for an 8 week period and will be given the opportunity to use non-combusted types of tobacco and medicinal tobacco products."
            }
        ], 
        "brief_summary": {
            "textblock": "The main focus of this study is to determine the use of nicotine-containing products across\n      the three experimental conditions. Subjects will be monitored to determine their continued\n      use of assigned cigarettes, switching to other combusted and/or non-combusted tobacco, or\n      cessation of all tobacco containing products."
        }, 
        "brief_title": "Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Tobacco Addiction", 
            "Dual Tobacco Use"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Tobacco Use Disorder", 
                "Behavior, Addictive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female subjects who are at least 18 years of age with a history of regular\n             smoking for at least 1 year and no serious quit attempts in the last 3 months\n\n          -  No unstable and significant medical or psychiatric conditions, including lack of\n             stabilization of medications.\n\n          -  Subject has provided written informed consent to participate in the study\n\n        Exclusion Criteria:\n\n          -  Regular use of tobacco products (including e-cigarettes) other than cigarettes\n\n          -  Regular use of nicotine replacement or other tobacco cessation products for purpose\n             of quitting.\n\n          -  Pregnant or breastfeeding (due to toxic effects from tobacco products).\n\n          -  Planned quit date within the next two months.\n\n          -  Does not have a way that the research team can communicate with them by phone or\n             e-mail.\n\n          -  Not able to read and write English well enough to complete study activities without\n             translation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02000921", 
            "org_study_id": "2013NTLS012"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "VLNC + combusted & non-combusted products", 
                    "VLNC with non-combusted products"
                ], 
                "description": "Modified risk tobacco product", 
                "intervention_name": "VLNC cigarettes", 
                "intervention_type": "Other", 
                "other_name": "Very Low Nicotine Content Cigarettes"
            }, 
            {
                "arm_group_label": [
                    "CN + combusted & non-combusted products", 
                    "VLNC + combusted & non-combusted products"
                ], 
                "description": "Options for combusted tobacco products include cigars, cigarillos, and little cigars, .", 
                "intervention_name": "Combusted Products", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "CN + combusted & non-combusted products", 
                    "VLNC + combusted & non-combusted products", 
                    "VLNC with non-combusted products"
                ], 
                "description": "Options for non-combusted tobacco products include smokeless tobacco, novel snus products, e-cigarettes and medicinal nicotine.", 
                "intervention_name": "Non-combusted products", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "CN + combusted & non-combusted products", 
                "description": "Experimental cigarettes with conventional nicotine content.", 
                "intervention_name": "CN cigarettes", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Cigarette Smoking", 
            "Very Low Nicotine Content cigarettes (VLNC)", 
            "Dual Tobacco Use"
        ], 
        "lastchanged_date": "December 20, 2013", 
        "location": {
            "contact": {
                "email": "jense010@umn.edu", 
                "last_name": "Joni A Jensen", 
                "phone": "612-624-5178"
            }, 
            "facility": {
                "address": {
                    "city": "Minneapolis", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55414"
                }, 
                "name": "University of Minnesota Tobacco Research Program"
            }, 
            "investigator": {
                "last_name": "Dorothy K Hatsukami, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Models for Tobacco Productive Evaluation: Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors", 
        "overall_contact": {
            "email": "jense010@umn.edu", 
            "last_name": "Joni A Jensen", 
            "phone": "612-624-5178"
        }, 
        "overall_official": {
            "affiliation": "University of Minnesota - Clinical and Translational Science Institute", 
            "last_name": "Dorothy K Hatsukami, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary aim of the study is to determine the rate of use of nicotine-containing products across the three experimental conditions.", 
            "measure": "Frequency of nicotine product switching", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02000921"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Masonic Cancer Center, University of Minnesota", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institutes of Health (NIH)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Masonic Cancer Center, University of Minnesota", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}